WVXU: Adjusting to work in today's high-tech age of automation
David Adams, chief innovation officer at the University of Cincinnati, and Hazem Said, professor and director of UC’s School of Information Technology, appeared on WVXU’s “Cincinnati Edition” Wednesday to discuss how the university is helping bring students and businesses together to meet the needs of today’s high-tech workplace. Adams discussed UC’s 1819 Innovation Hub while Said spoke about the university’s Information Technology programs.
Adams and Said were joined by Rich Hill, leader of strategy and architecture for Merchant Solutions at FIS, as well as Mark Muro and Robert Maxim of the Brookings Institute. The program is part of WVXU’s ongoing series, “American Graduate: Getting to Work.”
Listen to an archive of the program here.
Featured image at top: Apprentices stand at workstations at the automation learning center at the Festo distribution facility, Wednesday, May 17, 2017 in Mason, Ohio. John Minchillo / AP
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.